Rick A. Nishimura et al. JACC 2019;73:

Slides:



Advertisements
Similar presentations
Overview Public Reporting Cardiovascular Data Recommendations.
Advertisements

Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis David H. Adams et al (U.S. CoreValve Clinical Investigators) Journal Club November.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: The STS-ACC Transcatheter Valve Therapy National.
Relation of aortic regurgitation to all-cause mortality in the transcatheter aortic valve replacement (TAVR) as-treated population of the Placement of.
Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis  Arman Kilic, MD, Ashish S.
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Of mice and men and surgical transcatheter aortic valve insertion
Insights from the NCDR® STS/ACC TVT Registry.
Annual Outcomes With Transcatheter Valve Therapy
Annual Outcomes With Transcatheter Valve Therapy
Nat. Rev. Cardiol. doi: /nrcardio
Public Reporting of Cardiovascular Data
Surgeon Involvement in Transcatheter Aortic Valve Replacement in the United States: A 2016 Society of Thoracic Surgeons Survey  Joseph E. Bavaria, MD,
An example adjunctive CT imaging in the management of aortic valve replacement dysfunction. An example adjunctive CT imaging in the management of aortic.
The Passions and Actions of Our Lives: Changing the World Around Us
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Ao, aorta; AR, aortic regurgitation; CFD, color-flow Doppler; LV, left ventricle; LV EDP, left ventricular end-diastolic pressure; PW, pulse-wave; SBP,
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting  John V. Conte, MD, Thomas G. Gleason, MD, Jon.
Transatlantic editorial on transcatheter aortic valve replacement
Johannes Steiner et al. JACC 2017;70:
Johannes Steiner et al. JACC 2017;70:
Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the.
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.
Johannes Steiner et al. JACC 2017;70:
Accounting for outcomes: Lies, damned lies, and statistics
Impact of Left Ventricular Systolic Function on Outcome of Correction of Chronic Severe Aortic Valve Regurgitation: Implications for Timing of Surgical.
Gorav Ailawadi, MD, Damien J. LaPar, MD, MS, Alan M. Speir, MD, Ravi K
Suggested pathway for assessment of aortic valve replacement dysfunction. Suggested pathway for assessment of aortic valve replacement dysfunction. Transthoracic.
Raghavendra Paknikar, BS, Jeffrey Friedman, BS, David Cron, BS, G
Miralem Pasic et al. JCIN 2015;8:1-9
2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry  Frederick L. Grover, MD, Sreekanth.
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach  Christian McNeely, MD, Alan Zajarias,
The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement  Thomas.
Nicolaj C. Hansson et al. JACC 2016;68:
Simultaneous transapical transcatheter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis  Adil H. Al Kindi,
Transcatheter aortic valve replacement in intermediate-risk patients
Michele Gallo, MD, Gino Gerosa, MD 
Transcatheter Aortic Valve Replacement: How I Teach It
Mintu P. Turakhia et al. JACEP 2016;2:
Percutaneous Transcatheter Closure of the Aortic Valve
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation  Aaron Martin, MD, Michael.
Kreton Mavromatis, MD, Vinod H
Nicole M. Bhave et al. JIMG 2018;11:
Nicole M. Bhave et al. JIMG 2018;11:
Nicole M. Bhave et al. JIMG 2018;11:
Glenn N. Levine et al. JACC 2011;58:e44-e122
Hans-Joachim Schäfers, MD 
Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend  G. Michael Deeb, MD, John Carroll, MD  The Journal.
Rick A. Nishimura et al. JACC 2014;63:e57-e185
Rick A. Nishimura et al. JACC 2014;63:e57-e185
Leslee J. Shaw et al. JIMG 2010;3:
Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
Matias B. Yudi et al. JACC 2018;71:
Commentary: When a choice is not an echo
Sung-Han Yoon et al. JACC 2017;69:
Rick A. Nishimura et al. JACC 2017;70:
Racing to the Rubicon  Michael J. Reardon, MD, Vinod H. Thourani, MD 
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Ander Regueiro et al. JACC 2017;69:
Orly Vardeny et al. JCHF 2016;4:
Ronald K. Binder et al. JCIN 2013;6:
Charanjit S. Rihal et al. JACC 2015;65:e7-e26
Stefan Toggweiler et al. JCIN 2016;9:
Presentation transcript:

Rick A. Nishimura et al. JACC 2019;73:2609-2635 Categorization of Sites Based on TAVR Volume and Risk-Adjusted Mortality This schematic categorizes TAVR programs by their case volumes and risk-adjusted clinical outcomes. Most programs have sufficient case volumes to achieve technical competence and acceptable results, although these volumes may not be sufficient to allow statistically valid quality assessments. A few programs may have adequate volumes to meet TAVR requirements and ensure statistically valid quality assessment but still appear to have suboptimal performance. These programs need to take immediate actions to improve their outcomes as it is likely they are underperforming. Some programs with lower volumes appear to have acceptable outcomes, but because of their small sample sizes, their outcome data are less statistically reliable. These programs must continue to assess their quality vigilantly. Finally, some programs have low volume and less than optimal outcomes. Although these outcomes are statistically less certain, action should be undertaken immediately to further assess and improve quality (26). TAVR indicates transcatheter aortic valve replacement. Rick A. Nishimura et al. JACC 2019;73:2609-2635 2019 American Association for Thoracic Surgery, the American College of Cardiology Foundation, the American Society of Echocardiography, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons